As of 2024-12-13, the Relative Valuation of Proteome Sciences PLC (PRM.L) is (26.70) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 2.75 GBP, the upside of Proteome Sciences PLC based on Relative Valuation is -1070.8%.
The range of the Relative Valuation is (29.29) - (35.84) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 35.7x | 24.1x |
| Forward P/E multiples | 15.6x - 26.9x | 16.0x |
| Fair Price | (29.29) - (35.84) | (26.70) |
| Upside | -1165.2% - -1403.4% | -1070.8% |
| Date | P/E |
| 2024-11-21 | -2.07 |
| 2024-11-20 | -2.07 |
| 2024-11-19 | -1.95 |
| 2024-11-18 | -2.08 |
| 2024-11-15 | -2.07 |
| 2024-11-14 | -2.04 |
| 2024-11-13 | -1.95 |
| 2024-11-12 | -2.03 |
| 2024-11-11 | -2.07 |
| 2024-11-08 | -2.03 |
| 2024-11-07 | -2.03 |
| 2024-11-06 | -2.04 |
| 2024-11-05 | -2.03 |
| 2024-11-04 | -1.99 |
| 2024-11-01 | -2.04 |
| 2024-10-31 | -1.88 |
| 2024-10-30 | -2.07 |
| 2024-10-29 | -2.05 |
| 2024-10-28 | -2.11 |
| 2024-10-25 | -2.10 |
| 2024-10-24 | -2.10 |
| 2024-10-23 | -2.10 |
| 2024-10-22 | -2.26 |
| 2024-10-21 | -2.26 |
| 2024-10-18 | -2.11 |
| 2024-10-17 | -2.11 |
| 2024-10-16 | -2.07 |
| 2024-10-15 | -2.25 |
| 2024-10-14 | -2.22 |
| 2024-10-11 | -2.14 |
| 2024-10-10 | -2.16 |
| 2024-10-09 | -2.26 |
| 2024-10-08 | -2.22 |
| 2024-10-07 | -2.22 |
| 2024-10-04 | -2.22 |
| 2024-10-03 | -2.23 |
| 2024-10-02 | -2.26 |
| 2024-10-01 | -2.19 |
| 2024-09-30 | -2.26 |
| 2024-09-27 | -2.26 |
| 2024-09-26 | -2.19 |
| 2024-09-25 | -2.26 |
| 2024-09-24 | -2.26 |
| 2024-09-23 | -2.22 |
| 2024-09-20 | -1.88 |
| 2024-09-19 | -2.26 |
| 2024-09-18 | -2.26 |
| 2024-09-17 | -2.26 |
| 2024-09-16 | -2.26 |
| 2024-09-13 | -2.14 |